Hematological malignancies encompass a diverse range of diseases, such as leukemia, lymphoma, and multiple myeloma, among others. Within the multidisciplinary treatment approach, radiation therapy ...

Annual meeting moves to the New York Marriott Marquis on October 13-16, marking a new chapter and providing a refreshed ...

Study expected to enroll 24 patients with the option to enroll an additional 45 patients at the recommended Phase 2 doseProtocol calls for three ...

DelveInsight's BCL-2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...

The growth of the BCL-2 inhibitors market is expected to be driven primarily by rising incidence, increased awareness and access to treatment, and the launch of emerging drugs such as Lisaftoclax ...

The next chapter in hematology is being written at City of Hope. For patients navigating blood cancers like leukemia, lymphoma or multiple myeloma, having access to specialized experts and the most ...

According to MarketsandMarkets™, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026, at a CAGR of 13.7%.

According to MarketsandMarketstm, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026, at a CAGR of 13.7%. Browse 300 market data Tables and 30 ...

According to MarketsandMarkets, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 billion in 2026 ...

Manisha Koirala (ovarian cancer), Lisa Ray (multiple myeloma), Anurag Basu (blood cancer), and Sanjay Dutt (lung cancer); here is how Bollywood fought cancer.

However, with these recommendations, patients with advanced blood cancers use hospice much less than patients with solid tumors. These advanced cancers include leukemia, lymphoma and multiple myeloma, ...